1-4 of 4
M Boiron
Close
Sort by
Journal Articles

Treatment with Amifostine, Topotecan and Cytarabine in 31 Consecutive Patients with High Risk Myelodysplastic Syndrome: A Phase II Trial.

Kamal Bouabdallah, MD, Frederic Bauduer, MD, Michel Renoux, MD, Arnaud Pigneux, MD, Reza Tabrizzi, MD, Fontanet Bijou, MD, Thibaut Legay, MD, Gerald Marit, MD, Josy Reiffers, MD, Jean M. Boiron, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 4709.
https://doi.org/10.1182/blood.V104.11.4709.4709
Published: 2004
Journal Articles

Treatment of hairy cell leukemia with recombinant alpha interferon: I. Quantitative study of bone marrow changes during the first months of treatment

G Flandrin, F Sigaux, S Castaigne, C Billard, M Aguet, M Boiron, E Falcoff, L Degos
Journal: Blood
Blood (1986) 67 (3): 817–820.
https://doi.org/10.1182/blood.V67.3.817.817
Published: 1986
Journal Articles

Intensive chemotherapy of hairy cell leukemia in patients with aggressive disease

F Calvo, S Castaigne, F Sigaux, M Marty, L Degos, M Boiron, G Flandrin
Journal: Blood
Blood (1985) 65 (1): 115–119.
https://doi.org/10.1182/blood.V65.1.115.115
Published: 1985
Journal Articles

Acute monoblastic leukemia: a clinical and biologic study of 74 cases

G Tobelem, C Jacquillat, C Chastang, MF Auclerc, T Lechevallier, M Weil, MT Daniel, G Flandrin, JL Harrousseau, G Schaison, M Boiron, J Bernard
Journal: Blood
Blood (1980) 55 (1): 71–76.
https://doi.org/10.1182/blood.V55.1.71.71
Published: 1980